Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Veracyte (VCYT) just unveiled an update.
At the Company’s Annual Meeting, stockholders elected two directors to serve until the 2025 annual meeting, with a clear majority voting in favor. Additionally, Ernst & Young LLP was ratified as the independent registered public accounting firm for 2024. The compensation of the Company’s named executive officers received a non-binding advisory approval. Furthermore, the 2023 Plan Amendment was approved by shareholders, signaling confidence in the company’s strategic direction and governance.
For detailed information about VCYT stock, go to TipRanks’ Stock Analysis page.
